NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome.
Mikiya IshiharaShigehisa KitanoShinichi KageyamaYoshihiro MiyaharaNoboru YamamotoHidefumi KatoHideyuki MishimaHiroyoshi HattoriTakeru FunakoshiTakashi KojimaTetsuro SasadaEiichi SatoSachiko OkamotoDaisuke TomuraIkuei NukayaHideto ChonoJunichi MinenoMuhammad Faris KairiPhuong Diem Hoang NguyenYannick SimoniAlessandra NardinEvan NewellMichael FehlingsHiroaki IkedaTakashi WatanabeHiroshi ShikuPublished in: Journal for immunotherapy of cancer (2022)
NCT02366546.